StockData
Baxter International Inc logo

Baxter International Inc (BAX) stock

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/304% above fair value
$25.81+0.07 (+0.27%)

Close on Nov 13, 2026Market cap $13.35BP/E –Yield 2.01%

Baxter International total assets

Total assets on the balance sheet at the end of each period.

Baxter International's total assets was $19.41B at Sep 30, 2026. For fiscal 2025 it was $20.06B, down 22.2% from the year before. Over ten years it grew -0.4% a year on average. The highest annual figure on record is $33.52B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.06B-22.2%
FY2024Dec 31, 2024$25.78B-8.8%
FY2023Dec 31, 2023$28.28B-0.0%
FY2022Dec 31, 2022$28.29B-15.6%
FY2021Dec 31, 2021$33.52B+67.4%
FY2020Dec 31, 2020$20.02B+10.0%
FY2019Dec 31, 2019$18.19B+15.7%
FY2018Dec 31, 2018$15.72B-8.1%
FY2017Dec 31, 2017$17.11B+10.1%
FY2016Dec 31, 2016$15.55B-25.8%
FY2015Dec 31, 2015$20.96B-19.8%
FY2014Dec 31, 2014$26.14B+3.6%
FY2013Dec 31, 2013$25.22B+23.7%
FY2012Dec 31, 2012$20.39B+6.9%
FY2011Dec 31, 2011$19.07B+9.1%
FY2010Dec 31, 2010$17.49B+0.8%
FY2009Dec 31, 2009$17.35B+12.7%
FY2008Dec 31, 2008$15.41B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$19.41B-7.8%
Q2 FY2026Jun 30, 2026$19.79B-6.0%
Q1 FY2026Mar 31, 2026$19.85B-6.8%
Q4 FY2025Dec 31, 2025$20.06B-22.2%
Q3 FY2025Sep 30, 2025$21.07B-21.0%
Q2 FY2025Jun 30, 2025$21.05B-20.0%
Q1 FY2025Mar 31, 2025$21.30B-23.3%
Q4 FY2024Dec 31, 2024$25.78B-8.8%
Q3 FY2024Sep 30, 2024$26.68B-13.0%
Q2 FY2024Jun 30, 2024$26.31B-5.6%
Q1 FY2024Mar 31, 2024$27.79B-1.8%
Q4 FY2023Dec 31, 2023$28.28B-0.0%
Q3 FY2023Sep 30, 2023$30.66B+9.6%
Q2 FY2023Jun 30, 2023$27.89B-12.4%
Q1 FY2023Mar 31, 2023$28.29B-13.5%
Q4 FY2022Dec 31, 2022$28.29B-15.6%
Q3 FY2022Sep 30, 2022$27.97B+41.2%
Q2 FY2022Jun 30, 2022$31.83B+61.7%
Q1 FY2022Mar 31, 2022$32.72B+68.1%
Q4 FY2021Dec 31, 2021$33.52B+67.4%
Q3 FY2021Sep 30, 2021$19.81B-1.4%
Q2 FY2021Jun 30, 2021$19.68B+1.1%
Q1 FY2021Mar 31, 2021$19.47B+2.0%
Q4 FY2020Dec 31, 2020$20.02B+10.0%
Q3 FY2020Sep 30, 2020$20.10B+16.2%
Q2 FY2020Jun 30, 2020$19.47B+11.2%
Q1 FY2020Mar 31, 2020$19.08B+17.4%
Q4 FY2019Dec 31, 2019$18.19B+15.7%
Q3 FY2019Sep 30, 2019$17.30B+3.0%
Q2 FY2019Jun 30, 2019$17.50B+6.0%
Q1 FY2019Mar 31, 2019$16.24B-3.6%
Q4 FY2018Dec 31, 2018$15.72B-8.1%
Q3 FY2018Sep 30, 2018$16.80B-4.2%
Q2 FY2018Jun 30, 2018$16.52B-2.6%
Q1 FY2018Mar 31, 2018$16.84B+7.6%
Q4 FY2017Dec 31, 2017$17.11B+10.1%
Q3 FY2017Sep 30, 2017$17.54B–
Q2 FY2017Jun 30, 2017$16.96B–
Q1 FY2017Mar 31, 2017$15.66B–
Q4 FY2016Dec 31, 2016$15.55B–

More Baxter International figures

See a number that looks wrong?